For the Inventor, By the Inventor

Enter assignee name

New South Wales, Australia

Peptide Technology Limited

USPTO Granted Patents = 14

Forward Citations = 383

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Deborah Ann Rathjen (9 out of 24 patents)

Antonio Ferrante (5 out of 11 patents)

Roger Aston (4 out of 17 patents)

4. Alfred Poulos (3 out of 5 patents)

5. Fred Widmer (3 out of 7 patents)

6. Jurgen Michaelis (3 out of 3 patents)

7. Timothy Elliot Trigg (2 out of 8 patents)

8. Merilyn Joy Sleigh (2 out of 3 patents)

9. Paul Adam Schober (1 out of 4 patents)

10. Michael Joseph Pitt (1 out of 2 patents)

11. Thomas Alistair Robertson (1 out of 1 patent)

12. Christopher John Easton (1 out of 2 patents)

13. David James Phipps (1 out of 3 patents)

14. Douglas Kevin MacFadden (1 out of 3 patents)

15. Penelope Reed Doob (1 out of 3 patents)

14 patents: Sort by Forward Citations

1. 6416757 - Tumor necrosis factor antibodies (2002-07-09),

2. 6376688 - Modified polyunsaturated fatty acids (2002-04-23),

3. 6121237 - Neutrophil stimulating peptides (2000-09-19),

4. 5998476 - Synthetic polyunsaturated fatty acid analogues (1999-12-07),

5. 5959087 - Tumour necrosis factor binding ligands (1999-09-28),

6. 5798335 - Method for the treatment or prevention of eczema/dermatitis (1998-08-25),

7. 5795859 - Peptide which abrogates TNF and/or LPS toxicity (1998-08-18),

8. 5795858 - Treatment or prevention of Crohn's disease and/or ulcerative colitis (1998-08-18),

9. 5767156 - Polyunsaturated fatty acids and uses thereof (1998-06-16),

10. 5756449 - Peptide T and related peptides in the treatment of inflammation, (1998-05-26),

11. 5644034 - Tumour necrosis factor binding ligands (1997-07-01),

12. 5587457 - Neutrophil stimulating peptides (1996-12-24),

13. 5561110 - Method for the treatment of the complications and pathology of diabetes (1996-10-01),

14. 5545408 - Biocompatible implant for the timing of ovulation in mares (1996-08-13),

Peptide Technology Limited is a leading company specializing in peptide synthesis, research, and production. With cutting-edge technology and expertise, we offer custom peptide synthesis services for various industries including pharmaceuticals, biotechnology, and research institutions. Our commitment to quality, innovation, and customer satisfaction sets us apart in the industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

14 Patents

#15 in New South Wales

#268 in Australia

#40,882 in the World

New South Wales, Australia

Peptide Technology Limited

Forward Citations = 383

24 inventors:

Deborah Ann Rathjen (9 out of 24 patents)

Antonio Ferrante (5 out of 11 patents)

Roger Aston (4 out of 17 patents)

4. Alfred Poulos (3 out of 5 patents)

5. Fred Widmer (3 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…